Novel Therapeutic Approaches for Myelodysplastic Syndromes: Going Beyond Hypomethylating Agents

This downloadable slideset contains emerging clinical data and new approaches for managing patients with myelodysplastic syndromes.
Rami S. Komrokji, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 835 KB
Released: June 3, 2019

Acknowledgements

Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by an educational grant from
Celgene Corporation

Related Content

Preview expert ITP abstract selections from ASH 2020 as part of conference coverage from Clinical Care Options (CCO)

David J. Kuter, MD, DPhil Released: November 24, 2020

CCO commentary from Shaji Kumar, MD, on key issues in the management of multiple myeloma

Shaji Kumar, MD Released: November 23, 2020

Expert commentary from Clinical Care Options (CCO) on challenges in diagnosing and treating patients with myelodysplastic syndromes (MDS)

Rami S. Komrokji, MD Released: November 20, 2020

Enter the characteristics of your patient with CLL into this online tool from Clinical Care Options (CCO) to see treatment recommendations from 5 experts

Jeff P. Sharman, MD
Program Director
Released: November 20, 2020

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue